当前位置:首页 - 行情中心 - 金城医药(300233) - 财务分析 - 资产负债表

金城医药

(300233)

  

流通市值:69.67亿  总市值:72.25亿
流通股本:3.70亿   总股本:3.84亿

资产负债表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
流动资产:
货币资金1,054,637,208.331,024,634,589.321,116,070,894.64921,597,083.14
衍生金融资产223,563.7720,507.2488,636.11-
应收票据及应收账款632,985,505.78703,572,095.23634,573,915.91576,591,450.13
其中:应收票据72,141,681.2995,565,702.9471,296,336.9245,216,000
应收账款560,843,824.49608,006,392.29563,277,578.99531,375,450.13
应收款项融资94,901,267.7190,990,637.62144,517,656.23189,915,894.08
预付款项35,633,225.0930,701,553.6927,628,291.4330,927,938.22
其他应收款合计7,702,091.888,952,616.449,221,783.8810,362,123.83
存货533,067,145.66501,281,573.25473,767,851.28558,191,958.23
其他流动资产11,668,633.029,127,239.7811,216,565.68,119,031.32
流动资产平衡项目0000
流动资产合计2,370,818,641.242,369,280,812.572,417,085,595.082,295,705,478.95
非流动资产:
长期股权投资18,756,329.5619,072,019.1619,558,679.9419,645,602.15
其他权益工具投资131,449,469.57128,449,469.57135,584,764.93135,584,764.93
固定资产2,358,668,639.512,314,066,382.72,336,389,576.182,327,423,151.89
在建工程82,441,502.64148,974,839.3127,346,754.29103,970,973.67
使用权资产6,042,248.714,785,004.76,043,374.875,408,408.14
无形资产532,892,629.24547,291,943.61539,012,199.32542,871,406.49
开发支出312,712,021.55295,134,428.87284,695,294.94303,695,209.23
长期待摊费用14,905,130.215,755,322.0815,966,442.4216,776,923.87
递延所得税资产68,504,642.0169,774,159.6453,316,084.3654,261,337.19
其他非流动资产3,312,511.543,494,946.6110,321,628.7931,904,707.8
非流动资产平衡项目0000
非流动资产合计3,529,685,124.533,546,798,516.243,528,234,800.043,541,542,485.36
资产平衡项目0000
资产总计5,900,503,765.775,916,079,328.815,945,320,395.125,837,247,964.31
流动负债:
短期借款54,000,00094,000,000194,000,000203,750,000
衍生金融负债---162,406.14
应付票据及应付账款725,690,459.7824,001,911.99723,202,382.54706,416,833.18
其中:应付票据249,934,953.95265,616,333.35228,199,781.36158,017,269.89
应付账款475,755,505.75558,385,578.64495,002,601.18548,399,563.29
合同负债46,446,623.2732,738,866.3768,443,842.3138,535,601.18
应付职工薪酬147,229,972.32196,388,765.5169,124,491.71147,172,732.82
应交税费39,120,344.3538,788,282.7229,417,781.0937,291,527.73
其他应付款合计289,414,054.61299,148,634.21347,183,496.55320,631,948.21
应付股利---3,199,700
一年内到期的非流动负债205,490,777.68109,957,297.0869,642,985.42155,406,041.03
其他流动负债3,145,202.755,302,132.967,219,952.592,885,473.75
流动负债平衡项目0000
流动负债合计1,510,537,434.681,600,325,890.831,608,234,932.211,612,252,564.04
非流动负债:
长期借款376,824,024.33346,698,313.9398,787,959.47293,944,435.04
租赁负债4,530,921.553,461,048.053,615,818.912,852,404.45
递延收益59,721,381.1861,595,377.2161,925,737.3164,393,414.25
递延所得税负债129,955,954.48122,939,258.08129,984,910.16131,763,329.59
非流动负债平衡项目0000
非流动负债合计571,032,281.54534,693,997.24594,314,425.85492,953,583.33
负债平衡项目0000
负债合计2,081,569,716.222,135,019,888.072,202,549,358.062,105,206,147.37
所有者权益(或股东权益):
实收资本(或股本)383,874,587383,874,587385,924,427385,924,427
资本公积2,327,697,793.592,327,697,793.592,358,652,311.42,385,487,662.39
减:库存股55,009,170-33,002,42433,002,424
其他综合收益30,084,361.7730,084,361.7735,435,833.2935,435,833.29
专项储备7,052,391.554,531,622.427,541,739.326,002,488.36
盈余公积129,697,477.26129,697,477.26115,815,925.36115,815,925.36
未分配利润921,219,151.46838,247,801.7809,903,753.38778,419,470.21
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计3,744,616,592.633,714,133,643.743,680,271,565.753,674,083,382.61
少数股东权益74,317,456.9266,925,79762,499,471.3157,958,434.33
股东权益平衡项目0000
股东权益合计3,818,934,049.553,781,059,440.743,742,771,037.063,732,041,816.94
负债和股东权益合计5,900,503,765.775,916,079,328.815,945,320,395.125,837,247,964.31
公告日期2024-04-252024-03-292023-10-252023-08-19
审计意见(境内)标准无保留意见
TOP↑